Top Markets
Coin of the day
BioSig Technologies, Inc. BioSig Technologies, Inc.

BioSig Technologies, Inc.

BSGM
Rang in Aktien #10875
BioSig Technologies, Inc., along with its subsidiaries, operates as a medical... BioSig Technologies, Inc., along with its subsidiaries, operates as a medical technology enterprise. Its core innovation is the PURE EP (precise uninterrupted real-time evaluation of electrograms electrophysiology) system. This proprietary signal processing platform, merging specialized hardware and software, tackles well-known difficulties in electrophysiological signal acquisition, empowering electrophysiologists to instantaneously view and analyze vital cardiac signals. The system further enhances the collection of intracardiac signals and diagnostic data crucial for atrial fibrillation procedures. Moreover, it is specifically engineered to overcome persistent obstacles that traditionally slow down and complicate cardiac catheter ablation. BioSig also holds a research agreement with the University of Minnesota, targeting the development of new treatments for sympathetic nervous system disorders. Additionally, it has a strategic partnership with the Mayo Foundation for Medical Education and Research, focused on creating an advanced AI and machine learning software solution tailored for its PURE EP platforms. Established in 2009, BioSig Technologies, Inc. is headquartered in Westport, Connecticut.
Aktienkurs
$5.52
Zuletzt synchronisiert: 2025-10-09
Marktkapitalisierung
$775.10M
Veränderung (1 Tag)
1.28%
Veränderung (1 Jahr)
15.48%
Land
US
Handel BioSig Technologies, Inc. (BSGM)

Kategorie

Gewinn für BioSig Technologies, Inc. (BSGM)
Gewinn im Sep 2025 TTM: $-40.62M
Laut den aktuellen Finanzberichten von BioSig Technologies, Inc. betragen die aktuellen Gewinne des Unternehmens $-40.62M. Im Jahr 2023 erzielte das Unternehmen einen Gewinn von $-28.69M, ein Rückgang im Vergleich zu dem Gewinn im Jahr 2022, der $-27.26M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von BioSig Technologies, Inc. von 2011 bis 2026
Gewinn am Ende jedes Jahres
Jahr Gewinn ändert
2026 (TTM) $-40.62M 292.84%
2024 $-10.34M -63.96%
2023 $-28.69M 5.24%
2022 $-27.26M -17.03%
2021 $-32.86M -44.44%
2020 $-59.14M 71.57%
2019 $-34.47M 99.81%
2018 $-17.25M 35.88%
2017 $-12.70M 9.57%
2016 $-11.59M 22.47%
2015 $-9.46M 11.67%
2014 $-8.47M -13.58%
2013 $-9.80M 310.90%
2012 $-2.39M 107.27%
2011 $-1.15M 0.00%
Gewinn ähnlicher Unternehmen oder Konkurrenten
Unternehmen Gewinn Gewinnunterschied Land
$7.51B -18,592.71%
US
$5.15B -12,774.81%
US
$5.56B -13,796.57%
IE
$3.86B -9,606.11%
US
- -
DE